Results 171 to 180 of about 7,021,374 (331)
Surrogate Endpoints in Regulatory Decision-Making. [PDF]
Jeng LJB, Siegel J.
europepmc +1 more source
This study investigated how PYCR1 inhibition in bone marrow stromal cells (BMSCs) indirectly affects multiple myeloma (MM) cell metabolism and viability. Culturing MM cells in conditioned medium from PYCR1‐silenced BMSCs impaired oxidative phosphorylation and increased sensitivity to bortezomib.
Inge Oudaert +13 more
wiley +1 more source
Decision Making in Pediatric Heart Failure and Transplant: A Qualitative Analysis of Parental Decision Making. [PDF]
Phillips KA +7 more
europepmc +1 more source
The changing decision-making narratives in 25 years of TEN-T policies
Ángel Aparicio
openalex +1 more source
Following high dose rate brachytherapy (HDR‐BT) for hepatocellular carcinoma (HCC), patients were classified as responders and nonresponders. Post‐therapy serum induced increased BrdU incorporation and Cyclin E expression of Huh7 and HepG2 cells in nonresponders, but decreased levels in responders.
Lukas Salvermoser +14 more
wiley +1 more source
Clinical Decision-Making Case: Intussusception. [PDF]
Milman B, Parnell S.
europepmc +1 more source
Decision-Making Support in Resource Management in Manufacturing Scheduling
Nafissa Yussupova, Dmitry Rizvanov
openalex +1 more source
A synthetic benzoxazine dimer derivative targets c‐Myc to inhibit colorectal cancer progression
Benzoxazine dimer derivatives bind to the bHLH‐LZ region of c‐Myc, disrupting c‐Myc/MAX complexes, which are evaluated from SAR analysis. This increases ubiquitination and reduces cellular c‐Myc. Impairing DNA repair mechanisms is shown through proteomic analysis.
Nicharat Sriratanasak +8 more
wiley +1 more source

